OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases
Yu Su, Bixi Sun, Xiaoshu Gao, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Development and Characterization of In Situ Gelling Nasal Cilostazol Spanlastics
Maryana Salamah, Mária Budai-Szűcs, Bence Sipos, et al.
Gels (2025) Vol. 11, Iss. 2, pp. 82-82
Open Access

Silicosis: from pathogenesis to therapeutics
Yang Bi-jun, Xiaoman Liu, Cheng Peng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Nano-formulated curcumin uptake and biodistribution in the fetal growth restricted newborn piglet brain
Nuo Xu, Julie A. Wixey, Kirat K. Chand, et al.
Drug Delivery and Translational Research (2025)
Closed Access

Protein and peptide delivery through respiratory pathway
Hemal Tandel, Kiruba Florence, Mitali Upadhyay, et al.
Elsevier eBooks (2025), pp. 227-286
Closed Access

Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain
Rinie Bajracharya, Alayna C Caruso, Laura J. Vella, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2014-2014
Open Access | Times Cited: 27

Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review
Fatemeh Moradi, Nasrin Dashti
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 2, pp. 133-148
Closed Access | Times Cited: 21

Chitosan/Cyclodextrin Nanospheres for Potential Nose-to-Brain Targeting of Idebenone
Federica De Gaetano, Nicola d’Avanzo, Antonia Mancuso, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1206-1206
Open Access | Times Cited: 20

Intranasal delivery: An attractive route for the administration of nucleic acid based therapeutics for CNS disorders
Pranav Shah, Manisha Lalan, Kalyani Barve
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19

Formulation strategies for nose-to-brain drug delivery in Alzheimer's disease
Manisha Vohra, Mohammad Amir, Amit Sharma, et al.
Health Sciences Review (2023) Vol. 6, pp. 100075-100075
Open Access | Times Cited: 12

Nanotheranostics revolutionizing neurodegenerative diseases: From precision diagnosis to targeted therapies
Riya Joshi, Hemi Missong, Jayapriya Mishra, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105067-105067
Closed Access | Times Cited: 11

Chitosan Hydrogel Doped with PEG-PLA Nanoparticles for the Local Delivery of miRNA-146a to Treat Allergic Rhinitis
Yu Su, Bixi Sun, Xiaoshu Gao, et al.
Pharmaceutics (2020) Vol. 12, Iss. 10, pp. 907-907
Open Access | Times Cited: 30

Wheat Germ Agglutinin—From Toxicity to Biomedical Applications
Gabrielė Balčiūnaitė, Mindaugas Dzikaras
Applied Sciences (2021) Vol. 11, Iss. 2, pp. 884-884
Open Access | Times Cited: 24

Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets
Smrithi Padmakumar, Praveen Kulkarni, Craig F. Ferris, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112812-112812
Open Access | Times Cited: 18

Star Polymer Nanomedicines─Challenges and Future Perspectives
Helen Forgham, Jiayuan Zhu, Ruirui Qiao, et al.
ACS Applied Polymer Materials (2022) Vol. 4, Iss. 10, pp. 6784-6796
Closed Access | Times Cited: 18

MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid βeta oligomer induced Alzheimer's like rat model
Maryam Bazrgar, Pariya Khodabakhsh, Leila Dargahi, et al.
Experimental Gerontology (2022) Vol. 164, pp. 111812-111812
Closed Access | Times Cited: 17

siRNA-Mediated Timp1 Silencing Inhibited the Inflammatory Phenotype during Acute Lung Injury
Ivan V. Chernikov, Yaroslav Staroseletz, I.S. Tatarnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1641-1641
Open Access | Times Cited: 10

Rivastigmine-DHA ion-pair complex improved loading in hybrid nanoparticles for better amyloid inhibition and nose-to-brain targeting in Alzheimer’s
Nikita Hinge, Himanshu Kathuria, Murali Monohar Pandey
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 190, pp. 131-149
Closed Access | Times Cited: 10

Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies
Li Du, Lin Chen, Fangfang Liu, et al.
International review of neurobiology (2023), pp. 255-297
Closed Access | Times Cited: 10

Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers
Hadel A. Abo El-Enin, Alaa S. Tulbah, Hany W. Darwish, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 886-886
Open Access | Times Cited: 9

Optimization of Nasal Liposome Formulation of Venlafaxine Hydrochloride using a Box-Behnken Experimental Design
Sulekha Khute, Rajendra Jangde
Current Therapeutic Research (2023) Vol. 99, pp. 100714-100714
Open Access | Times Cited: 9

Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's
Nikita Hinge, Himanshu Kathuria, Murali Monohar Pandey
Applied Materials Today (2021) Vol. 26, pp. 101303-101303
Closed Access | Times Cited: 20

Therapeutic nanotechnologies for Alzheimer’s disease: A critical analysis of recent trends and findings
Philippe Delbreil, Jean‐Michel Rabanel, Xavier Banquy, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114397-114397
Closed Access | Times Cited: 15

Scroll to top